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Abstract
Introduction Increasing evidence indicates that epidural
anesthesia improves postoperative pulmonary function. The
underlying mechanisms, however, remain to be determined.
Because pulmonary nitric oxide has been identified to play a
critical role in pulmonary dysfunction in sepsis, we hypothesized
that thoracic epidural anesthesia (TEA) modulates endothelial
dysfunction via a nitric oxide-dependent pathway.
Methods Thirty-six Sprague-Dawley rats underwent sham
laparotomy or induction of peritoneal sepsis caused by cecal
ligation and puncture (CLP). Septic animals were then treated
with either bupivacaine 0.5% or normal saline epidurally (15 μl/
h-1) for 6 hours or 24 hours after injury. Previous experiments
demonstrated that these time points correspond with a
hyperdynamic (at 6 hours) and hypodynamic circulation (at 24
hours), respectively. In addition, two sham control groups
received either bupivacaine 0.5% or normal saline epidurally (15
μl/h-1). Six and 24 hours after injury, hemodynamic
measurements and arterial blood gas analyses were performed
in awake, spontaneously breathing rats. Exhaled nitric oxide,
bradykinin-induced pulmonary vasoconstriction (a surrogate
marker of endothelial dysfunction), pulmonary wet/dry-weight
ratio (an estimate of pulmonary edema), and myeloperoxidase
activity (MPO, a surrogate marker of neutrophil infiltration into
lung tisssue) were investigated at 6 and 24 hours by using an
established model of isolated and perfused lungs.
Results In hyperdynamic sepsis, treatment with TEA resulted in
reduced bradykinin-induced pulmonary vasoconstriction (P <
0.05) and lower levels of exhaled NO as compared with those in
untreated septic rats (P < 0.05). However, the development of
pulmonary edema or MPO activity in the lungs was not alleviated
by sympathetic blockade in this phase of sepsis. Conversely,
TEA led to an increased bradykinin-induced pulmonary
vasoconstriction and pulmonary edema despite reduced exNO
levels and pulmonary MPO activity in hypodynamic sepsis (each
P < 0.05 versus CLP 24 h). Pulmonary gas exchange was only
marginally affected under the influence of TEA in hypodynamic
sepsis. Mean arterial pressure and heart rate were not affected
beyond the changes caused by sepsis itself.
Conclusions The results of the present study suggest that TEA
modulates the NO pathway and exerts positive effects on
pulmonary endothelial integrity only in hyperdynamic sepsis.
Whether the negative effects on endothelial function in
hypodynamic sepsis have an impact on overall morbidity and
mortality remains to be determined in future studies.
Introduction
Thoracic epidural analgesia (TEA) is one of the most versatile
and widely used neuronal deafferentation techniques to
reduce effectively intraoperative sympathetic stimulation
resulting from surgical trauma [1]. TEA is therefore an integral
part of a multimodal concept to accelerate rehabilitation after
major abdominal and thoracic surgery and is increasingly
incorporated into therapeutic strategies in critical care medi-
cine [2-4]. Whether TEA is also useful to accelerate the recov-
ery of high-risk patients with severe sepsis and septic shock is
still not fully understood.
ABE: actual base excess; BK: bradykinin; CLP: cecal ligation and puncture; exNO: exhaled nitric oxide; iNOS: inducible nitric oxide synthase; MAC: 
minimum alveolar concentration; MPO: myeloperoxidase activity; NO: nitric oxide; OD: outer diameter; TEA: thoracic epidural anesthesia; VSMC: vas-
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In severe sepsis, pulmonary endothelial dysfunction plays a
pivotal role in the development of respiratory failure [5]. In this
context, overproduction of nitric oxide (NO) in the lungs has
been identified as a major cause for the emergence of
endothelial dysfunction and pulmonary edema [6,7]. Likewise,
increasing evidence suggests that TEA attenuates pulmonary
endothelial injury in ventilated patients after major abdominal
surgery. A recently published meta-analysis outlined that TEA
reduced the rate of respiratory failure and the duration of
required ventilation in those patients [8].
We hypothesized that TEA modulates pulmonary endothelial
dysfunction in sepsis via an NO-dependent pathway. The cur-
rent study was therefore conducted as a prospective, rand-
omized, controlled laboratory experiment to clarify whether
and how TEA affects the pulmonary endothelial dysfunction
typically seen in the presence of sepsis. Because the early
phase of hyperdynamic circulation is typically followed by a
late hypodynamic circulatory state in rats with sepsis second-
ary to cecal ligation and puncture (CLP) [9], another objective
of this study was to determine the effects of TEA in the differ-
ent phases of sepsis. These aims were investigated by using
an established model of isolated and perfused rat lungs
[10,11].
Materials and methods
After approval of the District Government, 36 male Sprague-
Dawley rats (Harlan Winkelmann, Borchen, Germany) weigh-
ing between 250 and 300 g were kept in a 12-hour light/dark
cycle and had free access to food and water. The animals
were included in the study after a 1-week acclimatization
period.
Animal preparation
Anesthesia was induced and maintained by isoflurane inhala-
tion (minimum alveolar concentration (MAC) 1.4 Vol. %). Dur-
ing instrumentation, spontaneous respiration was maintained.
Central venous and arterial lines (0.96 mm OD) (Liquiscan,
Ueberlingen, Germany) were introduced via the right external
jugular vein and the left carotid artery, respectively. Epidural
catheters (0.61 mm OD) were inserted at the levels of L3/L4
and advanced to T6. A repeated negative liquid-aspiration test
excluded subdural position of the catheter tip. All catheters
were protected by a swivel device. After completion of the
experimental protocol, the position of the catheter was verified
in each animal by autopsy. This model of continuous thoracic
epidural analgesia in permanently instrumented awake rats
has been shown consistently to produce stable thoracic sym-
pathetic blockade while maintaining hemodynamic stability
[12-14].
A midline laparotomy incision was made, and the cecum was
ligated just distal to the ileocecal valve so that continuity was
preserved. The cecum was then punctured twice with an 18-
gauge needle. Thereafter, the bowel was returned to the peri-
toneal cavity, and the wound was closed in two layers. Rats
were then allowed to awaken. Fluid resuscitation with NaCl
0.9% (6 ml/kg-1/h-1) was started postoperatively and contin-
ued throughout the in vivo experiment until the aorta was
ligated for the isolation and perfusion of the lungs. Fentanyl
(Janssen Cilag GmbH, Neuss, Germany; 2 μg/100-1 g/h-1)
was continuously infused to ensure adequate analgesia [10].
Experimental protocol
Because previous experiments demonstrated that CLP sepsis
corresponds with a hyperdynamic (2 to 10 hours after CLP)
and hypodynamic circulation (later than 18 hours after CLP)
with a transition from a hyperdynamic to a hypodynamic circu-
lation between 10 and 20 hours, the effects of TEA on pulmo-
nary endothelial dysfunction were determined at 6 and 24
hours, respectively, after CLP [15,16]. Taking into considera-
tion that endothelial integrity did not differ between 6 and 24
hours in sham animals in previous studies [17], sham-operated
animals were investigated at 24 hours only.
After the instrumentation, rats were randomly divided into six
groups (n = 6 each) by using a sealed and numbered envelope
system. To ensure that the investigator was blinded to the
study-group assignment, a technical assistant conducted the
laparotomy procedure and the preparation of the epidural infu-
sion. The SHAM group received a sham laparotomy followed
by continuous TEA with normal saline (15 μl/h-1 for 24 hours,
SHAM); the SHAM + TEA group underwent sham laparotomy
followed by continuous TEA with isobaric bupivacaine 0.5%
(15 μl/h-1 for 24 hours, SHAM + TEA). In the hyperdynamic
sepsis group (6 hours after injury), normal saline (15 μl/h-1)
was continuously administered epidurally for 6 hours after
induction of CLP sepsis (CLP 6 h). The TEA-treated hyperdy-
namic sepsis group received CLP + continuous TEA with iso-
baric bupivacaine 0.5% (15 μl/h-1) for 6 hours (CLP 6 h +
TEA). In the hypodynamic sepsis group, normal saline (15 μl/
h-1) was continuously infused through the epidural catheter for
24 hours (CLP 24 h). The TEA-treated hypodynamic sepsis
group received a continuous epidural infusion of isobaric bupi-
vacaine 0.5% (15 μl/h-1) for 24 hours after injury (CLP 24 h +
TEA). Concentrations of bupivacaine were used as described
previously [10,13].
Six and 24 hours after sham laparotomy or induction of perito-
nitis, respectively, mean arterial pressure (MAP), heart rate
(HR), and respiratory rate were measured, and blood was
withdrawn from the arterial catheter in awake, spontaneously
breathing rats. Arterial hemoglobin, hematocrit, pH, paO2,
paCO2, HCO3
-, actual base excess (ABE), leukocytes, and
arterial serum lactate concentrations were determined with
blood gas analysis (ABL, 620 Radiometer, Copenhagen, Den-
mark).Available online http://ccforum.com/content/13/4/R109
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Isolated perfused lungs
After hemodynamic measurements and blood gas analysis,
rats were again anesthetized with intraperitoneally injected α-
chloralose (50 mg/kg-1; Sigma Chemicals, Deisenhofen, Ger-
many) and urethane (650 mg/kg-1, Sigma Chemicals) and
were then tracheostomized with a 17-gauge cannula. The
lungs were mechanically ventilated with warmed (35°C) and
humidified 21% O2, 5% CO2, and balanced N2 by using a
rodent ventilator (tidal volume, 1 ml/100 g-1; frequency, 60
breaths/min-1; Harvard Apparatus GmbH, Deisenhofen, Ger-
many). End-expiratory pressure was set at 1 mm Hg.
For isolated lung perfusion, a sternotomy was conducted, fol-
lowed by excision of sections of the right and left anterior
chest wall to expose heart and lungs. After heparinization (100
U), rats were partly exsanguinated by needle aspiration (5 to 6
ml). A steel cannula (13-gauge) connected to the perfusion
system was inserted through the pulmonic valve into the main
pulmonary artery by incision in the right ventricle. A suture tied
around the pulmonary artery and aorta secured the cannula.
The latter prevented systemic blood flow. The circle was
closed by a cannula (3.5 mm outside diameter) that was
inserted through the apex of the left ventricle and secured with
umbilical tape. The isolation and perfusion procedure strictly
followed an established and standardized technique [10,17].
The perfusate consisted of the rat's own blood (added to the
perfusate after lung isolation) diluted with physiologic salt
solution (containing in mmol/L: 119.0 NaCl, 4.7 KCl, 1.17
MgSO4 × 7 H2O, 22.6 NaHCO3, 1.18 KH2PO4, 3.2 × 2 H2O,
5.6 dextrose) to a hematocrit of 9% to 12%. Indomethacin (30
μg/ml-1) was added to block prostaglandin synthesis. The per-
fusate drained from the left ventricle to a glass reservoir and
was heated to 38°C by a circumferential water jacket. With a
peristaltic pump (Harvard Apparatus), the perfusate was
returned to the pulmonary artery at constant flow (16 ml/min-
1). The isolated lung preparation remained in the thoracic cav-
ity lying supine and was warmed with a heating lamp. A
warmed and humidified chamber was placed over the thoracic
cavity to maintain thoracic temperature at 37°C. Reservoir pH
was continuously monitored (Hanna Instruments) and main-
tained at 7.35 to 7.45 by addition of HCl or NaOH, as
required. Pulmonary artery pressure (Pa) was continuously
monitored by using a pressure transducer (Becton Dickinson,
Singapore). Mean pulmonary venous pressure was set at 2
mm Hg by adjusting the height of the reservoir and was held
constant. Normoxic (21% O2) and hypoxic (3% O2) gas mix-
tures were administered through individual flowmeters. The
inspired O2 concentration was monitored (Oxydig, Draeger,
Germany) near the tracheal tube. The model of the isolated
and perfused lungs is illustrated in Figure 1. After thoracotomy
and stabilization of isolation and perfusion of the lung, recep-
tor-mediated vasoconstriction was studied, as described later.
Exhaled NO
Exhaled NO (exNO) was used as a surrogate marker for pul-
monary NO production [18]. Before the isolation and per-
fusion of the lungs, the exhaled air from the rats' lungs was
collected in a bag for 10 minutes. The exNO concentration
was analyzed with a TE 42S NOx analyzer (Thermo Environ-
ment, Franklin, MA, USA) by using an established protocol
[10].
Receptor-dependent pulmonary vasoconstriction
Integrity of vascular smooth muscle cell (VSMC) function is
critical for the regulation of the vascular tone. In this study, the
potent receptor-mediated vasoconstrictor angiotensin II (Ang
II, 0.1 μg; Sigma Chemicals) was injected into the inflow tract
of the isolated perfused lung circuit to test possible functional
impairment of VSMCs caused by sympathetic blockade or
sepsis. Changes in perfusion pressure were measured in mil-
limeters of mercury and expressed as pressure difference (Δp)
from baseline pressure [10,17,19].
To test pulmonary endothelial dysfunction, bradykinin (BK)-
induced vasoconstriction was evaluated by injecting increas-
ing concentrations of BK (1, 3, and 6 μg; Sigma Chemicals)
into the inflow circuit. Each dose was administered 5 minutes
after the perfusion pressure returned to baseline levels.
Changes in perfusion pressure were measured in millimetres
of mercury and expressed as Δp from baseline pressure
[11,17,20].
Figure 1
Illustration of the isolated and perfused lung model Illustration of the isolated and perfused lung model. After anesthesia 
and tracheostomy, exhaled NO (exNO) from rat's lungs was measured, 
followed by isolation and perfusion of the pulmonary circuit. Angi-
otensin II (Ang II) was injected into the inflow tract of the circuit to test 
vasoreactivity. Changes in perfusion pressure (Δp) from baseline were 
measured in millimeters of mercury. After a stabilization phase, bradyki-
nin (BK)-induced pulmonary vasoconstriction was induced. Therefore, 
increasing concentrations of BK (1, 3, and 6 μg) were injected into the 
inflow tract. Changes in perfusion pressure were measured in mm Hg 
and expressed as Δp from baseline pressure.Critical Care    Vol 13 No 4    Lauer et al.
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Myeloperoxidase (MPO) activity
After the experiment, right lungs were immediately frozen and
stored at -70°C until use. MPO, indicating pulmonary neu-
trophil infiltration, was measured in equal-sized samples of the
right lungs by using an established protocol [21]. Results were
expressed as microunits of MPO per milligram of protein of
supernatant, as determined by bicinchoninic acid assay
(Pierce Chemical Co., Rockford, IL, USA).
Pulmonary wet- to dry-weight ratio
Pulmonary bloodless wet- to dry-weight ratio was determined
at the end of the experiment. The left bronchus was carefully
separated from the right bronchus and tied, and the left lung
was severed. The lung was weighted immediately and dried at
60°C in an oven for 4 days to determine the ratio of wet-lung
weight (WW) to dry-lung weight (DW). The dry-lung weight
became stable after 48 hours of desiccation in our study [10].
Statistical analysis
Sigma Stat. 3.1 (Systat Software GmbH, Erkrath, Germany)
software was used for statistical analysis. After confirming nor-
mal distribution of all values (Kolmogorov-Smimov test), a two-
way analysis of variance for repeated measurements was per-
formed to detect potential differences within and between
groups. In case of significant group differences, post hoc com-
parisons were made by using the Student-Newman-Keuls test.
Bradykinin-induced vasoconstriction was expressed as the
peak Pa minus baseline Pa. For all statistical tests, significance
was assumed when P was less than 0.05. Data are presented
as mean ± SEM.
Results
Systemic and pulmonary effects in healthy animals and 
healthy animals with TEA
Healthy animals (SHAM) exhibited stable HR and MAP, which
were not affected by the use of TEA (SHAM + TEA). Leuko-
cyte count was higher in healthy animals treated with TEA than
in SHAM animals without TEA (P < 0.05). Arterial blood gases
were similar between SHAM and SHAM + TEA animals
(Tables 1 and 2).
Pulmonary MPO activity and exNO levels did not differ
between SHAM + TEA and SHAM (Figure 2 and Table 1). Pul-
monary endothelial integrity was maintained as indicated by
the absence of bradykinin-induced pulmonary vasoconstric-
tion (Figure 3). In addition the pulmonary wet/dry-weight ratio
and myeloperoxidase activity remained unchanged under the
treatment with TEA (Table 1).
VSMC function in SHAM + TEA animals, as indicated by
unchanged Ang II-induced pulmonary vasoconstriction was
not different from that in SHAM (Figure 4).
Systemic and pulmonary effects of TEA in hyperdynamic 
sepsis
In hyperdynamic sepsis (6 hours after injury), MAP and HR
remained unchanged in untreated (CLP 6 h) and TEA-treated
septic rats (CLP 6 h + TEA) when compared with SHAM
(Table 1). CLP 6 h + TEA animals had a significantly lower res-
piratory rate than did hyperdynamic rats without treatment and
SHAM animals (P < 0.05 versus CLP 6 h + TEA and SHAM;
Table 1). Leukocyte count was significantly reduced in animals
with sympathetic blockade when compared with the SHAM
Table 1
Systemic hemodynamics, respiration, hemoglobin, and biochemical markers of the different groups
Variable SHAM SHAM + TEA CLP 6 h CLP 6 h + TEA CLP 24 h CLP 24 h + TEA
HR
(beats/min)
396 ± 20 412 ± 24 387 ± 23 412 ± 30 464 ± 16#* 442 ± 37
MAD
(mm Hg)
139 ± 3 130 ± 9 129 ± 8 145 ± 5 133 ± 3 126 ± 6
RR
(rate/minute)
107 ± 8 95 ± 9 94 ± 9 74 ± 6# 130 ± 7#* 115 ± 5
Lactate (mmol/dl) 0.95
(0.9/1.2)
1.1
(1.0/1.53)
1.25
(1.1/1.45)
1.1
(0.93/1.4)
2.3#*
(1.83/3.1)
1.4§
(1.3/1.8)
Leukocytes
(1,000/μl)
5,217 ± 309 7,184 ± 552# 3,868 ± 878 3,194 ± 771# 2,076 ± 343#* 1,752 ± 552#
Hb
(g/dl)
15.6 ± 0.5 14.8 ± 0.2 15.3 ± 0.7 14.3 ± 1.2 14.9 ± 0.2 14.4 ± 1.0
MPO (μU/mg protein) 0.48
(0.42/0.57)
0.47
(0.42/0.81)
0.92
(0.87/1.08)#
0.97
(0.83/1.1)#
2.0
(1.91/2.17)#
0.26
(0.2/1.4)§
W/D 4 ± 1.4 4.4 ± 0.2 5.5 ± 0.2# 5.4 ± 0.3# 5.5 ± 0.2# 5.5 ± 0.1#
Measurements were performed in awake rats. HR = heart rate; MAD = mean arterial pressure; RR = respiratory rate. Data are expressed as mean 
± SEM or median, 25%, and 75% percentile. #P < 0.05 versus SHAM; †P < 0.05 versus all CLP groups, §P < 0.05 versus same group without 
TEA; *P < 0.05 versus hyperdynamic sepsis (CLP 6 h).Available online http://ccforum.com/content/13/4/R109
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group (P < 0.05 versus SHAM; Table 1). No changes in pul-
monary gas exchange were detected between the two hyper-
dynamic sepsis groups and SHAM animals (Table 2).
TEA prevented the increase of exNO concentrations in hyper-
dynamic sepsis, which was comparable to levels of healthy
animals (P < 0.05 versus CLP 6 h; Figure 2). In contrast, MPO
activity remained elevated, independent of sympathetic block-
ade (P < 0.05 versus SHAM; Table 1). The development of
pulmonary endothelial dysfunction was attenuated under the
treatment with TEA, as indicated by reduced bradykinin-
induced pulmonary vasoconstriction (P < 0.05 versus CLP 6
h; Figure 3). Pulmonary edema remained increased in CLP 6 h
and CLP 6 h + TEA (P < 0.05 versus SHAM; Table 1).
Ang II-induced pulmonary vasoconstriction remained
unchanged in rats with hyperdynamic sepsis with and without
sympathetic blockade and was comparable to those of SHAM
animals (Figure 4).
Systemic and pulmonary effects of TEA in hypodynamic 
sepsis
In hypodynamic sepsis (24 hours after injury), untreated ani-
mals (CLP 24 h) developed profound tachycardia, tachypnea,
leukopenia, and increased serum-lactate levels when com-
pared with healthy animals and with hyperdynamic sepsis (all
P values <0.05 vs. SHAM and CLP 6 h; Table 1). Pulmonary
gas exchange in the CLP 24 h group remained unchanged
when compared with SHAM (Table 2). Under the treatment
with TEA (CLP 24 h +TEA), hemodynamic variables did not
differ from those in healthy animals, and serum-lactate levels
were lower than those in untreated animals with hypodynamic
Table 2
Arterial blood gas analysis of the different groups in awake rats spontaneously breathing room air
Variable SHAM SHAM + TEA CLP 6 h CLP 6 h + TEA CLP 24 h CLP 24 h + TEA
pH 7.44 ± 0.01 7.47 ± 0.02 7.42 ± 0 7.42 ± 0.01 7.44 ± 0 7.36 ± 0.03#§
PaCO2 38 ± 0 38 ± 0 40 ± 0 41 ± 2 37 ± 0 47 ± 2#§
PaO2 97 ± 2 92 ± 3 100 ± 2 100 ± 5 93 ± 2 86 ± 6#
HCO3- 24.8 ± 0.3 26.9 ± 1.2 25.3 ± 0.3 26.3 ± 0.9 25.8 ± 1.3 24.9 ± 1
ABE 1.0 ± 1 3.5 ± 1 1.3 ± 0 2.3 ± 1 1.5 ± 0.5 -0.4 ± 1.4
Data are expressed as median ± SEM. #P < 0.05 versus SHAM; §P < 0.05 versus same group without TEA. ABE = actual base excess.
Figure 2
Exhaled NO (parts per billion) in sham animals, early and late sepsis,  when compared with sham and septic animals treated with TEA (bupi- vacaine 0.5%; n = 6 in each group) Exhaled NO (parts per billion) in sham animals, early and late sepsis, 
when compared with sham and septic animals treated with TEA (bupi-
vacaine 0.5%; n = 6 in each group). #P < 0.05 versus SHAM; §P < 
0.05 versus groups without TEA. Data are expressed as mean ± SEM.
Figure 3
Comparison of bradykinin (BK)-induced vasoconstriction in isolated  perfused rat lungs for evaluation of endothelial dysfunction (n = 6 in  each group) Comparison of bradykinin (BK)-induced vasoconstriction in isolated 
perfused rat lungs for evaluation of endothelial dysfunction (n = 6 in 
each group). The difference in perfusion pressure due to different con-
centrations of BK (1, 3, and 6 μg) is demonstrated. Data are presented 
as mean ± SEM. #P < 0.05 versus SHAM; §P < 0.05 versus the same 
group without TEA; * P < 0.05 versus BK, 6 μg, within group.Critical Care    Vol 13 No 4    Lauer et al.
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sepsis (P < 0.05 versus CLP 24 h; Table 1). Arterial blood gas
analysis revealed a decrease in PaO2 values when compared
those in healthy animals (P < 0.05 versus SHAM) and an
increase in paCO2 in TEA-treated rats when compared with
CLP 24 h and SHAM (P < 0.05 versus SHAM and CLP 24 h;
Table 2).
Sympathetic blockade reduced exNO and MPO activity below
levels seen in the SHAM group (P < 0.05 versus CLP 24 h;
Table 1 and Figure 2) but increased bradykinin-induced pul-
monary vasoconstriction in contrast to the CLP 24 h group (P
< 0.05 versus CLP 24 h and SHAM; Figure 3). Pulmonary
edema was elevated in both treated and untreated hypody-
namic sepsis (P  < 0.05 versus SHAM; Table 1). Ang II-
induced pulmonary vasoconstriction remained unchanged in
TEA-treated and untreated hypodynamic sepsis and were
comparable to the results of the SHAM group (Figure 4).
Discussion
In the present study, the impact of a regional thoracic sympa-
thetic blockade on pulmonary endothelial function was investi-
gated in both hyperdynamic and hypodynamic sepsis by using
an established rodent CLP model [11,13,17]. The major find-
ings were (a) that implementation of TEA in hyperdynamic sep-
sis reduced pulmonary endothelial dysfunction, whereas
sympathetic blockade in hypodynamic sepsis resulted in a
deterioration of endothelial integrity, (b) that treatment with
TEA exhibited antiinflammatory effects with modulation of the
NO pathway in both hyperdynamic and hypodynamic sepsis,
and (c) that TEA reduced neutrophil migration into the lungs
only in hypodynamic sepsis.
One of the most established and clinically relevant sepsis
models is the CLP procedure followed by fluid resuscitation
and analgesia. It is a typical feature of this model that the time
course of sepsis and the diversity of the bacterial flora closely
mimic the clinical situation [9]. In this context, it is noteworthy
that the CLP sepsis model is characterized by a biphasic
hemodynamic response. Notably, an early hyperdynamic
phase (2 to 10 hours after CLP) is followed by a hypodynamic
circulatory phase between 10 and 20 hours [15,16]. Although
several studies already addressed hemodynamic and intesti-
nal effects of epidural anesthesia in CLP sepsis [14], it was
still unclear whether (a) TEA has an impact on pulmonary
endothelial (dys)function, and (b) the effects of sympathetic
blockade on endothelial dysfunction differ in hyperdynamic
and hypodynamic sepsis.
One established technique to investigate pulmonary endothe-
lial dysfunction is the measurement of bradykinin-induced pul-
monary vasoconstriction in isolated and perfused rat lungs
[11,17]. In this context, Fischer and colleagues [11,17] dem-
onstrated that administration of bradykinin into the pulmonary
circuit results in a paradoxic vasoconstriction through BK2
receptors when the endothelial layer is injured after a septic
insult [11,17]. In contrast, healthy control lungs with an intact
endothelial layer lacked this bradykinin-induced vasoconstric-
tion. In accordance with the observation of Fischer and asso-
ciates [11,17,20], we also demonstrated that in hyperdynamic
sepsis, administration of bradykinin resulted in a paradoxic pul-
monary vasoconstriction in the current study. This effect was
not seen in healthy animals and in healthy animals treated with
TEA, indicating that animals of the two sham groups did not
have endothelial injury. However, impairment of pulmonary
VSMC function may have been responsible for a reduced
vasoconstrictive response to bradykinin in the different
groups. In this regard, it recently was reported that pulmonary
VSMC function is affected at different stages of sepsis,
thereby modulating pulmonary vasoconstriction [22]. There-
fore, we decided to test VSCM function to exclude its influ-
ence by stimulating the receptor with Ang II as a different
second messenger. With the observation of a uniform vaso-
constrictive response in the different groups, it is unlikely that
an impairment of VSMC function has contributed to the differ-
ences of bradykinin-induced pulmonary vasoconstriction
among groups.
Pulmonary NO has been identified as a key mediator in the
pathogenesis of endothelial dysfunction in both experimental
sepsis and the clinical setting [17,23]. In animal sepsis mod-
els, selective inhibitors of the inducible NO synthase resulted
in decreased exNO levels and significantly attenuated bradyki-
nin-induced pulmonary vasoconstriction [17,19]. In this con-
text, it is another finding of our study that TEA exhibited
Figure 4
Angiotensin II-induced pulmonary vasoconstriction to test pulmonary  smooth muscle cell function in healthy animals, early sepsis (CLP 6 h)  and late sepsis (CLP 24 h) compared with groups receiving treatment  with thoracic epidural anesthesia (TEA, n = 6 in each group) Angiotensin II-induced pulmonary vasoconstriction to test pulmonary 
smooth muscle cell function in healthy animals, early sepsis (CLP 6 h) 
and late sepsis (CLP 24 h) compared with groups receiving treatment 
with thoracic epidural anesthesia (TEA, n = 6 in each group). Data are 
expressed as mean ± SEM.Available online http://ccforum.com/content/13/4/R109
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antiinflammatory properties by suppressing exNO as a surro-
gate marker of iNOS activity in both hyperdynamic and hypo-
dynamic sepsis and additionally reduced neutrophil influx into
the lungs in the hypodynamic phase. However, this antiinflam-
matory effect reduced endothelial dysfunction only in the
hyperdynamic phase, whereas the impact of sympathetic
blockade in hypodynamic sepsis promoted a deterioration of
endothelial function. These results were somewhat unex-
pected, because iNOS generation from neutrophils and alve-
olar macrophages is known to play a critical role in the
development of septic lung injury [6,24]. Moreover, Farley and
colleagues [25] recently identified iNOS from alveolar macro-
phages as a key mediator in the development of pulmonary
microvascular endothelial cell septic barrier dysfunction. One
of the major roles of alveolar macrophages is to facilitate the
recruitment of circulating neutrophils to the lungs, through pro-
duction and release of neutrophil cytokines [26]. In addition,
depletion of alveolar macrophages has been shown to attenu-
ate septic neutrophil influx directly in murine septic lung injury
[27]. Although not directly measured in our study, the present
data suggest that TEA-related attenuation of MPO activity and
reduction of exNO levels in the lungs may be dependent on
changes of alveolar macrophage activity. This assumption is
supported by a study of Fujii and colleagues [6], who demon-
strated that inhibition of alveolar macrophages eliminated the
increase in lung iNOS activity and protein expression and sig-
nificantly attenuated the increase in pulmonary exNO product
in endotoxemic rats.
The fact that TEA did not exhibit protective properties on
endothelial integrity in hypodynamic sepsis despite its antiin-
flammatory action may be explained by a study of Traeger and
colleagues [28], who reported that selective depletion of pul-
monary alveolar macrophages increased lung injury in a perito-
nitis sepsis model by attenuating the defense mechanisms
against gut-derived bacteria in the lungs. Our data are further
supported by the observation of others that suppression of
NO production reduces endothelial dysfunction in hyperdy-
namic sepsis [17]. However, this is the first study showing that
the effects of sympathetic blockade time-dependently change
their characteristics with the development of hypodynamic
sepsis. In this regard, it is likely that TEA-related suppression
of neutrophil migration and NO production reduced the host
defense in the lungs, thereby deteriorating endothelial dys-
function [28]. Because we cannot exclude the possibility of
negative cardiovascular effects under sympathetic blockade
as a trigger for increased pulmonary endothelial dysfunction,
future studies are needed to address this issue in more detail.
This study has some limitations. First, the characteristic of this
isolated perfused rat-lung model is an ex vivo investigation of
pulmonary effects. Although this model is an established tech-
nique for studies of lung pathology [17,19,20,29] and allows
measurements in the pulmonary circuit that are impossible in
in vivo settings, further work is needed to confirm our findings
in vivo. Second, we cannot exclude effects of systemic
absorption of epidurally applied bupivacaine and subsequent
antiinflammatory pulmonary effects. It was recently reported
that intravenously administered local anesthetics accounted
for reduced lung injury in different animals sepsis models
[30,31], so further studies are needed to clarify the role of
intravenously applied local anesthetics on inflammatory
response in the presence of sepsis. Third, this experiment was
not carried out to investigate the safety of TEA in critical ill-
ness, but to identify the effects of TEA on the pulmonary
endothelial integrity. Although the use of TEA exhibited hemo-
dynamic stability in hyperdynamic and hypodynamic sepsis,
we are unable to comment on TEA-related actions on other
organ systems. In this regard, however, it is noteworthy that
the use of TEA in both hypodynamic and hyperdynamic endo-
toxemic sheep did not impair hemodynamics beyond the
changes caused by endotoxin itself [32,33]. Although the use
of TEA in critically ill patients has gained increasing interest in
the recent years, its use in the intensive-care setting remains
controversial [2-4]. Therefore, further studies are needed to
assess the efficacy and safety of TEA in critical illness.
Conclusions
In summary, this study demonstrates for the first time that TEA
exerts protective effects on pulmonary endothelial integrity
only in hyperdynamic sepsis. Whether the negative effects on
endothelial function in hypodynamic sepsis have an impact on
overall morbidity and mortality remains to be determined in
future studies.
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Key messages
￿  Implementation of TEA reduced pulmonary endothelial 
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with modulation of the NO pathway in both hyperdy-
namic and hypodynamic sepsis.
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